Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes
Sang-Sup Whang, Chang‐Keun Cho, Eui Hyun Jung, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 8, pp. 584-595
Closed Access | Times Cited: 10

Showing 10 citing articles:

Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19
Hye-Jung Park, Sangho Lee, Pureum Kang, et al.
Archives of Pharmacal Research (2025)
Closed Access
PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine
Chang-Keun Cho, Pureum Kang, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 5, pp. 481-504
Closed Access | Times Cited: 4
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
Pureum Kang, Chang‐Keun Cho, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 5, pp. 438-447
Closed Access | Times Cited: 8
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
Chang‐Keun Cho, Ji‐Young Byeon, Pureum Kang, et al.
Archives of Pharmacal Research (2022) Vol. 46, Iss. 2, pp. 111-116
Closed Access | Times Cited: 13
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
Ji‐Young Byeon, Chang‐Keun Cho, Pureum Kang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 8, pp. 713-721
Closed Access | Times Cited: 6
Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes
Chang‐Keun Cho, Pureum Kang, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 11-12, pp. 939-953
Closed Access | Times Cited: 6
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone
Chang‐Keun Cho, Ji‐Young Byeon, Pureum Kang, et al.
Archives of Pharmacal Research (2022) Vol. 46, Iss. 1, pp. 59-64
Closed Access | Times Cited: 10
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes
Chang‐Keun Cho, Eunvin Ko, Ju Yeon Mo, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 1, pp. 82-94
Closed Access | Times Cited: 5
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism
Chang‐Keun Cho, Ju Yeon Mo, Eunvin Ko, et al.
Archives of Pharmacal Research (2023) Vol. 47, Iss. 2, pp. 95-110
Closed Access | Times Cited: 4
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes
Chang-Keun Cho, Pureum Kang, Choon‐Gon Jang, et al.
Archives of Pharmacal Research (2024)
Closed Access
Page 1

Scroll to top